Fresenius Kidney Care Executive and Leadership Team

Surasak Kitseree, the Chief Financial Officer at Fresenius Kidney Care, directs all fiscal planning and capital allocation strategies. Overseeing the financial health of outpatient dialysis operations, the Chief Financial Officer ensures rigorous budget management across the entire network. This leadership role involves analyzing market trends to optimize resource distribution and maintain operational efficiency. By implementing robust financial controls, Surasak Kitseree directly impacts the long-term sustainability of patient care services. Furthermore, Kitseree manages investor relations and reporting requirements to support the broader organizational mission. Through precise fiscal oversight, the Chief Financial Officer secures the necessary funding for facility upgrades and technological advancements. Ultimately, Kitseree drives the financial stability required to provide consistent, high-quality renal care to patients across the United States, ensuring that every dollar spent contributes to superior clinical outcomes and operational excellence within the competitive healthcare landscape.

Abdellah Aitslimane, the Chief Financial Officer & Head of Support Services at Fresenius Kidney Care, manages the intersection of fiscal strategy and operational infrastructure. Overseeing the integration of support services into the core dialysis business model, the Chief Financial Officer & Head of Support Services ensures that administrative functions align with clinical requirements. This leadership role involves streamlining supply chain logistics and facility maintenance to enhance patient experiences. By optimizing internal support systems, Abdellah Aitslimane directly impacts the efficiency of outpatient centers. Furthermore, Aitslimane coordinates with regional directors to standardize service delivery protocols across the national footprint. Through meticulous management of support operations, the Chief Financial Officer & Head of Support Services reduces overhead costs while maintaining high standards of care. Ultimately, Aitslimane strengthens the organizational backbone, allowing clinical teams to focus entirely on delivering life-sustaining dialysis treatments to patients throughout the country.

Dennis Kogod, the President at Fresenius Kidney Care, architects the overarching strategic vision for the entire organization. Overseeing the expansion of outpatient dialysis services, the President ensures that clinical quality remains the primary focus of all business activities. This leadership role involves guiding the executive team toward achieving growth targets while maintaining compliance with healthcare regulations. By fostering a culture of innovation, Dennis Kogod directly impacts the development of new patient care models. Furthermore, Kogod engages with stakeholders to promote the importance of accessible renal care on a national scale. Through decisive leadership, the President navigates complex market challenges to sustain the company's position as a leader in the dialysis industry. Ultimately, Kogod drives the strategic initiatives that define the future of the organization, ensuring that every outpatient center provides consistent, compassionate, and effective treatment to patients requiring long-term renal support.

Ryan Valle, the President & Senior VP, Azura Vascular Care & , Strategic Development Care Delivery (US) at Fresenius Kidney Care, directs the growth of specialized vascular services. Overseeing the strategic development of care delivery models, the President & Senior VP, Azura Vascular Care & , Strategic Development Care Delivery (US) ensures that vascular access remains a priority for dialysis patients. This leadership role involves expanding the reach of Azura Vascular Care to improve patient outcomes across the United States. By integrating advanced vascular procedures into the existing care network, Ryan Valle directly impacts the quality of life for individuals undergoing dialysis. Furthermore, Valle collaborates with clinical leaders to refine treatment protocols and enhance service accessibility. Through targeted development strategies, the President & Senior VP, Azura Vascular Care & , Strategic Development Care Delivery (US) strengthens the company's comprehensive approach to renal health. Ultimately, Valle ensures that vascular care remains a cornerstone of the organization's commitment to excellence.

C. Haron, the President & Senior VP, Freseniusrx & Fresenius Medical Care (North America) at Fresenius Kidney Care, manages pharmaceutical operations and regional service delivery. Overseeing the integration of pharmacy services with dialysis care, the President & Senior VP, Freseniusrx & Fresenius Medical Care (North America) ensures that patients receive comprehensive medication management. This leadership role involves optimizing the supply chain for essential renal medications across North America. By streamlining pharmaceutical distribution, C. Haron directly impacts the continuity of care for thousands of patients. Furthermore, Haron coordinates with regional leadership to ensure that pharmacy services meet the specific needs of outpatient centers. Through strategic oversight of Freseniusrx, the President & Senior VP, Freseniusrx & Fresenius Medical Care (North America) enhances the overall value proposition of the company. Ultimately, Haron drives the operational success of pharmaceutical initiatives, ensuring that medication access remains reliable and efficient for all patients within the network.